PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
61.55
ESG score 80-90% of INKT's 68.97. Walter Schloss would scrutinize governance quality and regulatory exposure.
53.79
Environmental score 90-95% of INKT's 59.45. Bill Ackman would demand clear environmental improvement catalysts.
66.06
Social score 80-90% of INKT's 76.83. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
64.79
Governance score 90-95% of INKT's 70.64. Bill Ackman would demand clear governance improvement catalysts.